C12N 2740/13042
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2740/13042 (Virus or viral particle as vehicle) appears on 9 US grants and 19 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 19
- Assignees
- 18
- Inventors
- 29
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 2 | 3 |
| 2023 | 1 | 2 |
| 2024 | 1 | 6 |
| 2025 | 2 | 2 |
| 2026 | 2 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Virus-like particle16 Jun 2026US 12,655,388 B2Autolus Limited
- CRISPR enzymes and systems24 Feb 2026US 12,559,774 B2Massachusetts Institute of Technology
- Methods and products for genetic engineering22 Jul 2025US 12,365,707 B2Centre National de la Recherche Scientifique (CNRS)
- Methods and products for genetic engineering21 Jan 2025US 12,202,860 B2Centre National de la Recherche Scientifique (CNRS)
- Methods and products for genetic engineering30 Jul 2024US 12,049,480 B2Centre National De La Recherche Scientifique (CNRS) Paris, FRANCE
- Methods and products for genetic engineering11 Dec 2025US 2025/0376492 A1Centre National de la Recherche Scientifique (CNRS)
- Compositions and methods for efficient in vivo delivery1 May 2025US 2025/0136950 A1Nvelop Therapeutics, Inc.
- Methods and products for genetic engineering12 Dec 2024US 2024/0409588 A1Centre National de la Recherche Scientifique (CNRS)
- Methods and products for genetic engineering11 Jul 2024US 2024/0228546 A9Centre National de la Recherche Scientifique (CNRS)
- Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules13 Jun 2024US 2024/0189247 A1
Most cited
By later US patents
- Methods and products for genetic engineering23US 10,968,253 B2Centre National de la Recherche Scientifique (CNRS) · 2021
- Methods and products for genetic engineering9US 11,649,264 B2Centre National de la Recherche Scientifique (CNRS) · 2023
- Crispr enzymes and systems2US 11,352,647 B2Massachusetts Institute of Technology · 2022
- Methods and products for genetic engineering2US 12,049,480 B2Centre National De La Recherche Scientifique (CNRS) Paris, FRANCE · 2024
- Methods and products for genetic engineering2US 12,202,860 B2Centre National de la Recherche Scientifique (CNRS) · 2025